Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

Published:2006-01-30 Issue:12 Volume:25 Page:1696-1708
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Patrawala L,Calhoun T,Schneider-Broussard R,Li H,Bhatia B,Tang S,Reilly J G,Chandra D,Zhou J,Claypool K,Coghlan L,Tang D G

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1209327.pdf

Reference39 articles.

1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF . (2003). Proc Natl Acad Sci USA 100: 3983–3988.

2. Beachy PA, Karhadkar SS, Berman DM . (2004). Nature 432: 324–331.

3. Bhatia B, Maldonado C, Tang S-H, Chandra D, Klein RD, Chopra D et al. (2003). J Biol Chem 278: 25091–25100.

4. Bhatia B, Tang S, Yang P, Doll A, Aumüeller G, Newman RA et al. (2005). Oncogene 24: 3583–3595.

5. Bhatt RL, Brown MD, Hart CA, Gilmore P, Ramani VAC, George NJ et al. (2003). Cytometry 54A: 89–99.

Cited by 840 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate cancer stem cells and their targeted therapies;Frontiers in Cell and Developmental Biology;2024-08-08

2. TSP50 facilitates breast cancer stem cell-like properties maintenance and epithelial-mesenchymal transition via PI3K p110α mediated activation of AKT signaling pathway;Journal of Experimental & Clinical Cancer Research;2024-07-20

3. Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrence;Frontiers in Oncology;2024-04-29

4. A vascularized breast cancer spheroid platform for the ranked evaluation of tumor microenvironment-targeted drugs by light sheet fluorescence microscopy;Nature Communications;2024-04-27

5. Heterocyclic Compounds and their Derivatives with Potential Anticancer Activity;Indian Journal of Pharmaceutical Education and Research;2024-03-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3